10/10/2024 | Raymond James | Reiterated Rating | Outperform | $36.00 | |
10/9/2024 | Oppenheimer | Boost Target | Outperform ➝ Outperform | $47.00 ➝ $53.00 | |
9/30/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 ➝ $51.00 | |
9/10/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 ➝ $51.00 | |
9/9/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
8/13/2024 | UBS Group | Lower Target | Buy ➝ Buy | $42.00 ➝ $41.00 | |
8/8/2024 | JPMorgan Chase & Co. | Lower Target | Overweight ➝ Overweight | $51.00 ➝ $46.00 | |
8/7/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
6/18/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
6/3/2024 | Oppenheimer | Lower Target | Outperform ➝ Outperform | $50.00 ➝ $46.00 | |
5/30/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
5/30/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 ➝ $51.00 | |
3/28/2024 | Oppenheimer | Initiated Coverage | Outperform | $50.00 | |
3/25/2024 | Truist Financial | Reiterated Rating | Buy ➝ Buy | $48.00 | |
3/13/2024 | The Goldman Sachs Group | Initiated Coverage | Buy | $50.00 | |
2/20/2024 | JPMorgan Chase & Co. | Initiated Coverage | Overweight | $51.00 | |
2/15/2024 | Wolfe Research | Initiated Coverage | Outperform | $55.00 | |
1/12/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
12/21/2023 | Bank of America | Boost Target | Buy ➝ Buy | $49.00 ➝ $51.00 | |
12/21/2023 | HC Wainwright | Boost Target | Buy ➝ Buy | $47.00 ➝ $51.00 | |
12/12/2023 | Deutsche Bank Aktiengesellschaft | Initiated Coverage | Buy | $50.00 | |
12/1/2023 | UBS Group | Boost Target | Buy ➝ Buy | $55.00 ➝ $56.00 | |
11/15/2023 | Truist Financial | Boost Target | Buy ➝ Buy | $30.00 ➝ $48.00 | |
10/24/2023 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $28.00 ➝ $57.00 | |
10/24/2023 | HC Wainwright | Boost Target | Buy ➝ Buy | $29.00 ➝ $47.00 | |
10/16/2023 | Cantor Fitzgerald | Boost Target | Overweight ➝ Overweight | $30.00 ➝ $45.00 | |
10/13/2023 | UBS Group | Upgrade | Neutral ➝ Buy | $18.00 ➝ $55.00 | |
10/9/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $30.00 | |
9/27/2023 | Guggenheim | Boost Target | | $32.00 ➝ $48.00 | |
9/27/2023 | Citigroup | Boost Target | Buy ➝ Buy | $33.00 ➝ $50.00 | |
9/27/2023 | Wells Fargo & Company | Boost Target | Overweight ➝ Overweight | $33.00 ➝ $48.00 | |
9/26/2023 | Truist Financial | Reiterated Rating | Buy ➝ Buy | $30.00 | |
9/26/2023 | Raymond James | Upgrade | Market Perform ➝ Outperform | $40.00 | |
9/22/2023 | Guggenheim | Reiterated Rating | Buy ➝ Buy | $32.00 | |
9/18/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $30.00 | |
8/22/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $30.00 | |
8/16/2023 | Truist Financial | Reiterated Rating | Buy ➝ Buy | $30.00 | |
8/11/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $29.00 | |
8/11/2023 | Citigroup | Boost Target | Buy ➝ Buy | $28.00 ➝ $33.00 | |
7/24/2023 | Wells Fargo & Company | Boost Target | Overweight | $27.00 ➝ $33.00 | |
7/18/2023 | Stifel Nicolaus | Boost Target | Buy | $28.00 ➝ $34.00 | |
7/18/2023 | HC Wainwright | Boost Target | Buy | $27.00 ➝ $29.00 | |
7/10/2023 | Chardan Capital | Reiterated Rating | Buy | | |
5/23/2023 | Bank of America | Boost Target | | $26.00 ➝ $28.00 | |
5/23/2023 | Guggenheim | Boost Target | | $30.00 ➝ $32.00 | |
5/23/2023 | HC Wainwright | Boost Target | | $26.00 ➝ $27.00 | |
5/22/2023 | Chardan Capital | Boost Target | | $21.00 ➝ $32.00 | |
5/1/2023 | Bank of America | Initiated Coverage | Buy | $26.00 | |
4/25/2023 | Citigroup | Initiated Coverage | Buy | $28.00 | |
3/31/2023 | Piper Sandler | Initiated Coverage | Overweight | $28.00 | |
3/29/2023 | Stifel Nicolaus | Initiated Coverage | Buy | $28.00 | |
3/20/2023 | HC Wainwright | Boost Target | | $21.00 ➝ $26.00 | |
2/15/2023 | Cantor Fitzgerald | Initiated Coverage | Overweight | $30.00 | |
2/13/2023 | Guggenheim | Upgrade | Neutral ➝ Buy | $30.00 | |
2/7/2023 | HC Wainwright | Boost Target | Buy | $17.00 ➝ $21.00 | |
2/6/2023 | Leerink Partners | Boost Target | Outperform | $14.00 ➝ $21.00 | |
2/5/2023 | Chardan Capital | Boost Target | Buy | $19.00 ➝ $21.00 | |
1/2/2023 | Wells Fargo & Company | Upgrade | Equal Weight ➝ Overweight | $10.00 ➝ $27.00 | |
11/17/2022 | Truist Financial | Boost Target | | $30.00 | |
11/8/2022 | Wells Fargo & Company | Boost Target | Equal Weight | $7.00 ➝ $10.00 | |
11/7/2022 | HC Wainwright | Boost Target | Buy | $16.00 ➝ $17.00 | |
11/7/2022 | Chardan Capital | Boost Target | Buy | $12.00 ➝ $19.00 | |
11/4/2022 | Leerink Partners | Boost Target | Outperform | $12.00 ➝ $14.00 | |
9/29/2022 | Chardan Capital | Lower Target | Buy | $14.00 ➝ $12.00 | |
9/26/2022 | UBS Group | Downgrade | Buy ➝ Neutral | $7.00 ➝ $5.00 | |
6/9/2022 | Robert W. Baird | Lower Target | | $6.00 | |
6/9/2022 | HC Wainwright | Reiterated Rating | Buy | $16.00 | |
5/20/2022 | UBS Group | Lower Target | | $7.00 | |
3/30/2022 | Chardan Capital | Lower Target | | $20.00 ➝ $14.00 | |
3/29/2022 | Chardan Capital | Reiterated Rating | Buy | | |
3/22/2022 | Chardan Capital | Reiterated Rating | Buy | | |
2/7/2022 | HC Wainwright | Reiterated Rating | Buy | $16.00 | |
1/5/2022 | Chardan Capital | Lower Target | Buy ➝ Buy | $22.00 ➝ $20.00 | |
12/30/2021 | Truist Financial | Reiterated Rating | Buy | $12.00 | |
12/8/2021 | Wells Fargo & Company | Initiated Coverage | Equal Weight | $9.00 | |
11/8/2021 | HC Wainwright | Lower Target | Buy | $19.00 ➝ $16.00 | |
10/26/2021 | Truist Financial | Lower Target | Buy | $24.00 ➝ $12.00 | |
8/13/2021 | Chardan Capital | Lower Target | Buy | $55.00 ➝ $22.00 | |
8/10/2021 | HC Wainwright | Reiterated Rating | Buy | $19.00 | |
8/3/2021 | Robert W. Baird | Downgrade | Outperform ➝ Neutral | $20.00 ➝ $10.00 | |
8/2/2021 | Credit Suisse Group | Downgrade | Neutral ➝ Underperform | $12.00 ➝ $7.00 | |
7/7/2021 | Chardan Capital | Reiterated Rating | Buy | | |
7/1/2021 | Chardan Capital | Reiterated Rating | Buy | | |
6/2/2021 | Credit Suisse Group | Boost Target | Neutral | $12.00 ➝ $26.00 | |
6/2/2021 | Leerink Partners | Lower Target | Outperform | $38.00 ➝ $17.00 | |
6/2/2021 | Robert W. Baird | Lower Target | Outperform | $32.00 ➝ $20.00 | |
6/2/2021 | HC Wainwright | Lower Target | Buy | $23.00 ➝ $19.00 | |
6/1/2021 | Raymond James | Downgrade | Outperform ➝ Market Perform | | |
6/1/2021 | Guggenheim | Downgrade | Buy ➝ Neutral | | |
6/1/2021 | Stifel Nicolaus | Downgrade | Buy ➝ Hold | $28.00 ➝ $9.00 | |
5/10/2021 | HC Wainwright | Lower Target | Buy | $33.00 ➝ $23.00 | |
2/16/2021 | Stifel Nicolaus | Reiterated Rating | Buy | $28.00 | |
2/3/2021 | Raymond James | Lower Target | Outperform | $58.00 ➝ $35.00 | |
2/3/2021 | Leerink Partners | Lower Target | Outperform | $52.00 ➝ $38.00 | |
2/3/2021 | HC Wainwright | Lower Target | Buy | $54.00 ➝ $33.00 | |
2/2/2021 | Credit Suisse Group | Downgrade | Outperform ➝ Neutral | | |
2/2/2021 | Stifel Nicolaus | Lower Target | Buy | $54.00 ➝ $33.00 | |
1/13/2021 | HC Wainwright | Reiterated Rating | Buy | $54.00 | |
11/13/2020 | Truist Financial | Boost Target | | $52.00 ➝ $62.00 | |
11/13/2020 | Robert W. Baird | Boost Target | Outperform | $47.00 ➝ $64.00 | |
11/13/2020 | HC Wainwright | Boost Target | Buy | $40.00 ➝ $54.00 | |
11/13/2020 | Leerink Partners | Boost Target | Outperform | $39.00 ➝ $52.00 | |
11/12/2020 | Chardan Capital | Boost Target | | $45.00 ➝ $60.00 | |
10/28/2020 | UBS Group | Initiated Coverage | Buy | $61.00 | |
10/12/2020 | Guggenheim | Initiated Coverage | Buy | $63.00 | |
10/7/2020 | Stifel Nicolaus | Initiated Coverage | Buy | $46.00 | |
10/6/2020 | Lifesci Capital | Reiterated Rating | Outperform | | |
10/2/2020 | CSFB | Initiated Coverage | Outperform | $49.00 | |
10/2/2020 | Credit Suisse Group | Initiated Coverage | Outperform | $49.00 | |
8/26/2020 | Truist Financial | Boost Target | | $36.00 ➝ $52.00 | |
8/26/2020 | HC Wainwright | Reiterated Rating | Buy | $34.00 ➝ $40.00 | |
8/25/2020 | Robert W. Baird | Boost Target | Outperform | $31.00 ➝ $47.00 | |
8/25/2020 | Chardan Capital | Boost Target | Positive ➝ Buy | $35.00 ➝ $45.00 | |
8/24/2020 | Raymond James | Initiated Coverage | Outperform | $35.00 | |
8/20/2020 | Leerink Partners | Boost Target | Outperform ➝ Outperform | $26.00 ➝ $34.00 | |
8/13/2020 | Chardan Capital | Boost Target | Buy | $30.00 ➝ $35.00 | |
8/5/2020 | Ci Capital | Reiterated Rating | Buy | $32.00 | |
7/29/2020 | HC Wainwright | Initiated Coverage | Buy | $34.00 | |
6/18/2020 | SunTrust Banks | Upgrade | Buy | | |
6/17/2020 | SunTrust Banks | Boost Target | | $24.00 ➝ $36.00 | |
5/29/2020 | Nomura | Boost Target | Buy | $27.00 ➝ $37.00 | |
5/29/2020 | Nomura Instinet | Boost Target | Buy | $27.00 ➝ $37.00 | |
3/4/2020 | Nomura Securities | Reiterated Rating | Buy | $27.00 | |
2/24/2020 | Leerink Partners | Initiated Coverage | Outperform | $24.00 | |
2/17/2020 | Chardan Capital | Reiterated Rating | Buy | | |
2/4/2020 | Nomura Securities | Initiated Coverage | Buy | $27.00 | |
1/10/2020 | SunTrust Banks | Initiated Coverage | Buy | $24.00 | |
1/9/2020 | Chardan Capital | Initiated Coverage | Buy | $30.00 | |
1/7/2020 | Robert W. Baird | Initiated Coverage | Outperform | $21.00 | |